Catalyst Pharmaceuticals Stock Momentum Indicators Aroon
| CPRX Stock | USD 21.48 0.36 1.70% |
| Symbol |
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Aroon Indicator was developed by Tushar S. Chande to indicate when a new trend is dawning. The indicator consists of two lines that measure how long it has been since the highest high/lowest low has occurred within an (N) period range. When Catalyst Pharmaceuticals Aroon Up is staying between 70 and 100 then it indicates an upward trend. When the Aroon Down is staying between 70 and 100 then it indicates an downward trend. A strong upward trend is indicated when the Aroon Up is above 70 while the Aroon Down is below 30. When Catalyst Pharmaceuticals Aroon Down crosses above the Aroon Up, it indicates a weakening of the upward trend (and vice versa).
Catalyst Pharmaceuticals Technical Analysis Modules
Most technical analysis of Catalyst Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Catalyst from various momentum indicators to cycle indicators. When you analyze Catalyst charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Catalyst Pharmaceuticals Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Catalyst Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Catalyst Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Catalyst Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Catalyst Pharmaceuticals's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Catalyst Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Catalyst Pharmaceuticals, we also check how macroeconomic factors affect Catalyst Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 17.15 | 17.79 | 49.05 | 44.0 | PTB Ratio | 3.38 | 6.4 | 4.61 | 4.38 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Catalyst Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Catalyst Pharmaceuticals' short interest history, or implied volatility extrapolated from Catalyst Pharmaceuticals options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Gambling Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Momentum Invested over 60 shares | |
 | Business Services Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Macroaxis Picks Invested over 40 shares | |
 | Disruptive Technologies Invested few shares | |
 | Blockchain Invested few shares | |
 | Driverless Cars Invested over 50 shares | |
 | Chemicals Invested over 30 shares | |
 | Investor Favorites Invested over 60 shares | |
 | Artificial Intelligence Invested few shares |
Additional Tools for Catalyst Stock Analysis
When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.